Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Sep 13 2024
Business
Sep 13 2024
3 min read

Press Release Sep 13 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 13, 2024, titled "Zydus announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable, contrast agents in the US.".

View Attachment